Crossmark

Changes in PCSK9 and LDL cholesterol concentrations by everolimus treatment and their effects on polymorphisms in PCSK9 and mTORC1

Published Online: 2020-03-25

Published Print: 2020-06

Authors

Sato, Shiori

Akamine, Yumiko

Kagaya, Hideaki

Saito, Mitsuru

Inoue, Takamitsu

Numakura, Kazuyuki

Habuchi, Tomonori

Satoh, Shigeru

Miura, Masatomo
License Information

Text and Data Mining valid from 2020-03-25

Version of Record valid from 2020-03-25
More Information

Article History

Received: 9 September 2019

Revised: 17 February 2020

Accepted: 20 February 2020

First Online: 25 March 2020

Compliance with ethical standards

:

: The authors report no conflicts of interest.

Document is current